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1048-90 Pregnancy Associated Plasma Protein-A Levels Are 
Elevated in Patients With Unstable Angina 
Ali E. Denktas, Patricia J. M. Best, Julie Woodrum, Michael T. Overgaard, Michael 
Christiansen, Claus Oxvig, David R. Holmes, Jr., Cheryl A. Conover, Amir Lerman. Mayo 
Clinic. Rochester, MN, University of Aarhus, Aarhus, Denmark 
Background: Pregnancy-associated plasma protein A (PAPP-A), recently identified as 
an insulin like growth factor (IGF) bmding protein proteinase, IS a high molecular weight 
zinc blnding metalloproteinase secreted by vascular smooth muscle cells. Increased 
PAPP-A activity leads to enhanced IGF bioactivity and may contribute to the progression 
of atherosclerosis. Thus, the current study was designed to test the hypothesis that circu- 
lating PAPP-A levels are elevated in patients (pts) with unstable angina (UA). Methods: 
Blood samples were taken from 333 pts undergoing cardiac catheterization at the Mayo 
Clinic. PAPP-A levels were analyzed using a biotin-tyramids-amplified enzyme immu- 
noassay. UA was defined as the new onset of angina1 symptoms (~6 weeks), rest paIn, 
or post infarction angina (within 3 weeks of Infarction). Control pts were those who had 
coronary disease and did not meet the requirements for UA or were undergoing routine 
cardiac catheterization for preoperative cardiac surgery such as valve repairfreplace- 
ment. ThIrtytwo pts with UA were identified and the circulating levels of PAPP-A were 
compared to the remaining pts. Clinical characteristics were identified through patlent 
interview and chart review. Coronary angiograms were reviewed for the extent of the dis- 
ease, which was defined as the number of major vessels with >70% stenosis. Results: 
The study group consisted of 333 pts, 223 (67%) were males, mean age 64+11. There 
were no differences in the age, gender, presence of diabetes, hypertension, family his- 
tory, cholesterol levels, smoking hastory of the pts with or without UA. The PAPP-A levels 
in the UA pts ware significantly higher than in the pts without VA (7.1 * 4.0 vs. 5.5 * 3.4 
mlU/L, p= 0.01, two sided p=O.O36). PAPP-A levels were associated with older age 
(pcO.OOl), male gender (p&005) and lower levels of high-density lipoprotein (p=O.OOZ). 
PAPP-A levels were not associated with the extent of the coronary artery disease. Con- 
clusion: Patients with unstable angina have higher levels of circulating PAPP-A than 
patients without unstable angina. PAPP-A may be marker for plaque instability. 
1048-91 Elevated C-Reactive Protein Levels Are Associated With 
Myocardial lschemia Early in the Course of Non-ST 
Elevation Coronary Syndromes 
Olaa Papadaki, Michael N Zairis. John A. Ambrose, Marla Thoma, Paraskevi 
Psarogianm, Stavros Manousakis, Olga Ampartzidou. Alexander Kardoulas, Mary 
DeVoe, Kostas Katsaros, Kostas Karidis, Stefanos Foussas. Tzanlo Hospital, Piraeus. 
Greece, The Comprehensive Cardiovascular Center, St. Vincent Catholic Medical 
Center, New York, NY 
Background High plasma levels of C-reactive protein (CRP) are associated with short- 
or long-term ischemic complications in patients with unstable coronary artery disease. 
However, a possible direct relationship of plasma CRP with spontaneous myocardial 
&hernia early I” the course of non ST elevation acute coronary syndromes (NSTACS) 
was not thoroughly investigated. 
MethodsTo evaluate this issue 172 consecutive patients with NSTACS with no elevated 
plasma cardiac troponin T levels upon admission (cTnT-zO.1 yojdl) who underwent a 24 
hour continuous IBlead electrocardiographic (ECG) monitoring were studied. The asso- 
ciatlon of plasma CRP levels upon admission with either the incidence or duration of the 
recorded myocardial ischemla (ST-segment shifts) was evaluated. Patients divided into 
three groups according to the tertiles of CRP values upon admission. 
Results During 3,696 hours of contmuous 12.lead ECG monitoring, 169 ST-segment 
shifts were recorded in 48 patients with a mean number of 3.5k2.0 shifts per patient and 
a mean duration of 29.6i23.6 min per episode, corresponding to a total duration of 
124.4k143.6 mm per patlent. There was a significant gradual increased risk for either the 
incidence (p<O.OOl) or the total duration of ST-segment shifts with increasing of CRP ter- 
tiles (p=O.Ol). MultivarIate analysis showed that CRP tertiles were independently and 
positively related to the occurrence of ST-segment shifts. 
Conclusions High plasma levels of CRP may be associated with a higher incidence of 
myocardial tschemia early III the tours.? of NSTACS, suggesting a direct relationship of 
inflammation in this process. 
1048-92 Coronary Expression of Heat Shock Protein 60 and 
Serum Antibody Levels in Patients With Acute Coronary 
Syndrome 
Rvu Shutta. Shiro Hoshida, Tamaki Itakura, Shmichiro Suna, Masayuki Taniike. 
Yasuyuki Egami. Kenjiro Tanaka, Takayoshi Adachi, Masami Nishino, Hideo Tanahashi, 
Jun Tanouchi, Yoshlo Yamada, Osaka Rosa1 Hospital, Osaka, Japan, Yao City Hospital, 
Osaka. Japan 
Background- The production of heat shock protein (HSP) in coronary arteries provokes 
an autoimmune reaction with the anti-HSP antibody. We examined the relation between 
the instability of ischemlc heart disease (IHD) and inflammatory cell Infiltration and HSP 
expression in coronary tissues as well as the serum levels of HSP antibody. Methods 
and Result+ Coronary specimens from 73 symptomatic patients (acute coronary syn- 
drome [ACS, n=33]; stable IHD, 1x40) who had undergone a coronary atherectomy were 
immunohistochemicallv tested for the exoression of human and chlamvdial HSPGO. 
HSP70, CD66 (macrophages) and CD3 (T lymphocytes). Specimens from ACS patients 
exhibited a sianificantlv broader area of stainina for CD66. CD3. and chlamvdial and - . 
human HSPGO, compared with stable IHD patients (8.4&6% vs 2.9r0.4%. 4.2+0.3% vs 
2.OiO 3%, 6.0*0.4% vs 2.4iO.3%, p<O.OOl, respectively, 11.3+0.9% v.s 7.7+0.7%, 
p<O.O05). A discriminant function analysis revealed that the expression of CD66 plus 
chlamydial and human HSPGO in the same lesions could clearly differentiate coronary 
specimens from ACS patients and specimens from stable IHD patients (accuracy 86.3%, 
F-value. 33.82). When blood samples were obtained from ACS patients (n=54) and sta- 
ble IHD patients (n=520), the levels of a&human HSPGO antibodies were significantly 
higher in ACS patients than in stable IHD patients (0.606~0.022 vs. 0.757+0.010, 
~~0.05). Conclusions- The coexistence of inflammatory cells and HSPGO associated 
with elevated serum levels of HSPGO antibodies may be related to the etiologic mecha- 
nisms of unstable plaque. 
1048-93 Coagulation Activation and Long-Term Outcome in 
Acute Coronary Syndromes 
Piera Anaelica Merlini, Kenneth A. Bauer, Diego Ardissino, Robert Rosenberg, Ospedale 
Niguarda, Milan, Italy 
Rationale. After an episode of unstable angina or myocardlal infarction, a high propor- 
tion of patients show biochemical signs of coagulation activation, expressed as persis- 
tently elevated thrombin generation, in their blood. It is not known whether this has any 
influence on long-term outcome. 
Objective. In this prospective multicenter cohort study we assessed the relation of per- 
sistently elevated thrombin generation to outcome in patients with acute coronary syn- 
dromes. A total of 319 consecutive patients with acute coronary syndromes enrolled in 
GUSTO Ilb trial.. Plasma prothrombin fragment I+2 levels, an index of ?n VIVO” thrombin 
generation, was measured during the acute phase and after one, six and 12 months, and 
Its relation to outcome was assessed during a median 29.month follow-up. 
Findings The primary end-point of cardiac death or myocardial (re)infarction occurred in 
61 patients (19%). There was a U-shaped relation between plasma prothrombin frag- 
ment It2 tevels and the risk of developing the primary end-point: Intermediate levels 
(1.5-l .9 nmoVL) were associated with the lowest risk, whereas both htgher (> 1.9 nmollL) 
and lower (cl .5 nmol/L) values were associated with an increased risk (RR 1.56, 95% 
confidence Interval 1.25-2.28; RR 1.35; 95% confidence intawal 1.1 l-1.66; respec- 
tively)Conclusions After an episode of acute coronary syndrome, both high and low lev- 
els of thrombin generation are predictors of an increased risk of an unfavourable 
outcome. 
1048-94 IL-6 Genotypic Polymorphism and IL-6 Levels in Acute 
Coronary Syndromes With and Without ST-Segment 
Elevation 
Athanassios Manainas Evgenia Bei, Nektarios Pilatis. Antigoni Chaidaroglou. Dlmitris 
Degiannis, Ekaterini Koniavitou, Dennis V. Cokkinos, Onassis Cardiac Surgery Center, 
Athens, Greece 
Background: Inflammation plays an important role in the pathogen&s of acute coronary 
syndromes (ACS) with ST-segment elevation (STSE) and without ST-segment elevation 
(NSTSE). Interleukin-6 (IL6) is an inflammatory marker with prognostic value in patients 
with coronary artery disease (CAD) and is elevated in ACS. 
Methods: We studied 66 consecutwe patients (aged 61*11 years, 56 males) admitted to 
our institution with ACS. Forty-seven patients (aged 63&, 39 males) presented with 
NSTSE and 21 (aged 57*15, 19 males) with STSE ACS. Clinical, electrocardiographic 
and laboratory parameters were recorded. Genotypic analysis of IL6 gene polymorphism 
G/C-174 was performed with the PCR-SSP technique. Quantitative assessment of 
serum IL6 levels was performed on a blood sample drawn within 46 hours from the last 
episode of chest pain. 
Results: The two groups had similar clinical characteristirzs and risk factors for CAD. 
Patients with STSE had a higher incidence of the C/C-174 polymorphwn compared with 
NSTSE patients, who had a higher incidence of the G/G-174 polymorphism. 
In multivariable analysis, independent markers of STSE group were the IL6 polymor- 
phism (O&5.4, 95% Cl 1.6-16.2, p=O.O03) and age (OR=0.91. 95% Cl 0.64-0.97, 
p=O.OOS). 
Conclusion: The genotypic polymorphism G/C-l74 of IL-6 gene may be related to the 
type of ACS (STSE or NSTSE). This association may be due to higher IL-6 production !n 
patients with the C allele in the IL-6 gene. 
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Conclusions: HNa occurs frequently dunng the acute phase of STEMI and is a strong 
NSTSE (n=47) STSE (n=21) IL6 levels (pg/ml) Independent predictor of increased short-term mortality. 
IL6 gene polymorphism 53% 
G/G (n=31) 43% 
G/C (n=30) 4.3% 
c/c (n=7) 
27% 3.2 * 2.9 
47% 7.2 * 9.9 
24% 13.1 * 15.4 
P value 0.025 (&#61539;2) 0.049 (Kr-Wallis) 
1048-95 C-Reactive Protein Levels as an Early Predictor of 30. 
Day Mortality in Patients With Acute Myocardial 
infarction 
Mahmoud A. Suleiman, Doron Aronson. Michael Kapeliovich. Arthour Kerner. Yishai 
Levy, Haim Hammenan, Rambam Medical Center, Haifa, Israel, Technion Faculty of 
Medicine, Haifa, Israel 
Background: In patients with unstable angina, elevated C-reactive protein (CRP) has 
been shown to predict recurrent coronary events. However, little data is available on the 
prognostic value of CRP in acute myocardial infarction (AMI), and its relation to mea- 
sures of infarct size. 
Methods: CRP was measured within 24-h of symptoms onset in a prospective series of 
348 consecutive patients (mean age 62 + 13 y, men - 76%) with AMI (260 with ST-eleva- 
tion AMI). Echocardiographic examination was performed on day 2 or 3. Thirty-day mor- 
tality was evaluated using Cox proportional-hazards model wtth the following covariates: 
age, gender, prior aspirin use, Killip class, diabetes, peak CK. SBP < 100 mm Hg, 
echocardiographic wall motion score index (WMSI). and repelfusion therapy (primary 
angioplasty or thrombolytic therapy). 
Results: Patients with CRP levels in the upper tertile (>2.2 mg/UL) had higher peak CK 
(1999 t 166 vs 1762 * 116, p = 0.01) and higher echocardiographic wall motion score 
index (1.6 * 0.4 vs 1.5 + 0.4, p < 0.0001). Kaplan-Meier surwal wives indicated that 
patients with CRP levels in the upper tertile were at Increased risk of 30.day mortality 
(Figure). In a Cox’s multivariate analysis, CRP level in the upper tertile was a significant 
and independent predictor of 30-day mortality (Relative Risk = 3.2, 95% Cl 1.2-6.2, p = 
0.007). 
Conclusion: CRP level on admission is a powerful predictor of 30-day mortality in 
patients with AMI independent of infarct size and other traditional predictors of outcome. 
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1048-96 Hyponatremia Is a Powerful Independent Predictor of 
Short-Term Mortality In Patients With Acute ST 
Elevation Myocardial Infarction 
Alexander Goldberq, Haim Hammerman, Sirouch Petcherski, Elena Koifman, Alexander 
Zdorovyak, Michael Kapeliovich, Walter Markiewicz, Doron Aronson. Rambam Medical 
Center, Haifa. Israel 
Background: Hyponatremia (HNa) is recognized as a predictor of adverse outcome in 
hospitalized patients (pts), especially in pts with heart failure. However, little is known 
about the prevalence and prognostic significance of HNa in pts with acute ST-elevation 
myocardial infarctjon (STEMI). 
Methods: We studied 706 consecutive pts (age 62 f 13, 75% male) with STEMI. Plasma 
sodium (Na) was measured on admission and at 24,46, and 72 hours thereafter. go-day 
mortality was evaluated using Cox proportional-hazards model, adjusting for important 
covariates including age, gender, diabetes, Killip class, peak CK, diuretic therapy, reper- 
fusion therapy (thrombolysis or primary angioplasty), ejection fraction, heart rate > 100, 
and svstolic blood oressure < 100 mm Ha on admission. 
Rest&: HNa (N&l35 mmol/L) developed during the first 72-h of hospital stay in 53% 
of Dts. Na decreased to 126.130 mmol/L in 29 ots and to<125 mmollL in 7 ots. Althouoh 
pti receiving diuretics developed HNa more commonly compared to pts who were not 
(64% vs. 46%, p < O.OOOl), the majority of pts (66%) who developed HNa were not 
receiving diuretics. Kaplan-Meyer survival curves indicated that pts who developed HNa 
were at increased risk of go-day mortality (Figure). In a Cox multivariate analysis, HNa 
remained a significant and independent predictor of go-day mortality (RR 3.0, 95% Cl 
1.3-6.5, p = 0.006). 
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1048-97 lschemia Modified Albumin: A New Biomarker of 
Myocardial lschemia for Early Diagnosis of Acute 
Coronary Syndromes 
Michael C. Kontos, Steven Schorer, James D. Kirk, Dana R. Fletcher, Debra L. Morris, 
Virginia Commonwealth University/Medical College of Virginia, Richmond, VA, Mercy 
Healthcare, Sacramento, CA 
Background: Chest paln is one of the most common reasons for emergency department 
(ED) visits in the US, accounting for about 6% of all visits. Identifying the etiology of chest 
pain is challenging and resource-intensive. Although Ml can be diagnosed using sensi- 
tive cardiac injury markers, currently no such marker is available for diagnosing 
ischemia. ED diagnosis is based on the physician’s clinical judgment using findings from 
the history, clinical exam, and diagnostic tests including the ECG and rest myocardial 
perfusion imaging (MPI). However, idenhfication is limited by the sub-optimal sensibvity 
of the ECG. Although MPI has higher sensitivity and negative predictive value (NPV), it is 
not wdely used due to its cost and complexity. lschemla Modified Albumin (IMATM) is 
produced when circulating albumin comes in contact with ischemic myocardium. IMA 
increases with ischemia and is detectable in serum prior to necrosis markers. IMA utility 
and diagnostic accuracy compared to traditional methods for diagnosing myocardial 
ischemia in the ED has not been well described. Methods: We are currently enrolling 
patients (pts)(target = 400) presenting to the ED with acute chest pain. Pts undergo rest 
MPI with either ongoing symptoms or within 1 hour of pain cessation. The ED ECG is 
recorded and serial sampling of IMA before and after rest MPI is performed. Diagnosis of 
ischemia is determined by expert cardiologists blinded to IMA values using all clinical 
data collected at presentation and during routine follow-up. Results: Data from the first 
127 patents was available for analysis; 54 males, 73 females; mean age 52 years (30- 
96). Final diagnosis was 14 positive and 113 negative for &hernia. Sensitivity of IMA 
(cutoff 85 UlmL), ECG, and MPI for ischemia was 71%, 21%, and 69%, respectively. 
NPV of IMA, ECG, and MPI was 90%, 91%, and 96%, respectively. Adding the ECG to 
IMA did not improve sensitivity over IMA alone, but combining results from IMA and MPI 
produced a sensitivity and NPV of 100% Conclusions: These preliminary results sug- 
gest that IMA improves the ability to diagnose myocardial &hernia in pts presenting to 
the ED with acute chest pain. 
1048-98 Early Detection of Myocardial lschemia by a Novel 
Blood-Based Biomarker: The Kinetics of lschemia 
Modified Albumin 
ChrlstoDher deFiliDDi, Samual Yoon, Christian Bounds, Linda Romar. Alexander Ro, 
William Herzog, Lawrence Stafford, Robert H. Christenson, University of Maryland, 
Baltimore, MD 
Background: Quantifying subtle myocardial injury IS now routine, however, early detec- 
tion of myocardial &hernia using serum biomarkers remains elusive. lschemia modified 
albumin@ (IMA) is a promising new blood test for detection of ischemia. We studied IMA 
in the setting of percutaneous coronary intervention (PCI) as a model of known transient 
ischemla. 
Methods: Eleven patients (pts) (age 60+1 I, 7 males) without evidence of ischemia for > 
7 days undergoing single-vessel PCI (6 RCA and 3 LAD) were enrolled. Blood was col- 
lected: pre-PCI after arterial access, <IO minutes post initial balloon inflation (post-lnfl), 
and 2.6, 9, 12. 16 hours (hr) post-PCI. Samples were tested for IMA, troponin T and CK- 
MB. 
Results: All patients had successful PCI, with mean longest and total balloon inflation 
times of 2.5+1 .I and 4.321.9 minutes, respectively. Pre-PCI mean IMA levels (95.4*7.2 
UlmL) increased in IO of 11 pts post-lnfl (104.9ilO.9 UlmL. P<O.OOl versus pre-PCI) 
(Figure). IMA levels post-PC1 at 2 hr (97.6+11.4 U/mL), 6 hr (91.0+12.2 UlmL), 9 hr, 12 hr 
and 16 hr were not significantly different from pre-PCI. Seven patients had ECG or 
echocardiographic evidence of ischemia with PCI, while 2 had post-PC1 injury measured 
by troponin T or CK-MB. 
